Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.
Shiuan E, Reddy A, Dudzinski SO, Lim AR, Sugiura A, Hongo R, Young K, Liu XD, Smith CC, O'Neal J, Dahlman KB, McAlister R, Chen B, Ruma K, Roscoe N, Bender J, Ward J, Kim JY, Vaupel C, Bordeaux J, Ganesan S, Mayer TM, Riedlinger GM, Vincent BG, Davis NB, Haake SM, Rathmell JC, Jonasch E, Rini BI, Rathmell WK, Beckermann KE. Shiuan E, et al. Among authors: mayer tm. Cancers (Basel). 2021 Mar 23;13(6):1475. doi: 10.3390/cancers13061475. Cancers (Basel). 2021. PMID: 33806963 Free PMC article.
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
Palmeri M, Mehnert J, Silk AW, Jabbour SK, Ganesan S, Popli P, Riedlinger G, Stephenson R, de Meritens AB, Leiser A, Mayer T, Chan N, Spencer K, Girda E, Malhotra J, Chan T, Subbiah V, Groisberg R. Palmeri M, et al. ESMO Open. 2022 Feb;7(1):100336. doi: 10.1016/j.esmoop.2021.100336. Epub 2021 Dec 23. ESMO Open. 2022. PMID: 34953399 Free PMC article.
Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation.
Lichtbroun BJ, Shinder B, Sara TG, Srivastava A, Saraiya B, Mayer TM, Cristelli R, Sadimin E, Weiss RE, Singer EA. Lichtbroun BJ, et al. Among authors: mayer tm. J Kidney Cancer VHL. 2023 Jul 8;10(3):1-8. doi: 10.15586/jkcvhl.v10i3.254. eCollection 2023. J Kidney Cancer VHL. 2023. PMID: 37441361 Free PMC article.
Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.
Srivastava A, Rivera-Núñez Z, Kim S, Sterling J, Farber NJ, Radadia KD, Patel HV, Modi PK, Goyal S, Parikh R, Mayer TM, Saraiya B, Sadimin ET, Weiss RE, Kim IY, Elsamra SE, Jang TL, Singer EA. Srivastava A, et al. Among authors: mayer tm. Cancer. 2020 Jul 1;126(13):2991-3001. doi: 10.1002/cncr.32912. Epub 2020 Apr 24. Cancer. 2020. PMID: 32329899 Free article.
Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database.
Farber NJ, Rivera-Núñez Z, Kim S, Shinder B, Radadia K, Sterling J, Modi PK, Goyal S, Parikh R, Mayer TM, Weiss RE, Kim IY, Elsamra SE, Jang TL, Singer EA. Farber NJ, et al. Among authors: mayer tm. Urol Oncol. 2019 Jan;37(1):26-32. doi: 10.1016/j.urolonc.2018.10.004. Epub 2018 Nov 13. Urol Oncol. 2019. PMID: 30446458 Free PMC article.
51 results